HF
AKBA icon

HRT Financial’s Akebia Therapeutics AKBA Stock Holding History

HRT Financial’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-976,937
Closed -$1.36M – 4091
2026
Q1 		$1.36M Sell
976,937
-642,399
-40% -$883K ﹤0.01% 1865
2025
Q4 		$2.61M Buy
1,619,336
+1,594,539
+6,430% +$3.34M 0.01% 1131
2025
Q3 		$67K Buy
+24,797
New +$82.5K ﹤0.01% 2566
2025
Q2 		– Sell
-46,726
Closed -$89K – 2533
2025
Q1 		$89K Buy
+46,726
New +$95.4K ﹤0.01% 2167
2024
Q1 		– Sell
-15,094
Closed -$18K – 2232
2023
Q4 		$18K Buy
+15,094
New +$15.4K ﹤0.01% 2044
2023
Q2 		– Sell
-148,681
Closed -$83K – 2393
2023
Q1 		$83K Buy
+148,681
New +$114K ﹤0.01% 2083
2022
Q4 		– Sell
-23,453
Closed -$7K – 2419
2022
Q3 		$7K Sell
23,453
-1,080,284
-98% -$424K ﹤0.01% 2565
2022
Q2 		$389K Buy
1,103,737
+1,078,469
+4,268% +$453K ﹤0.01% 1848
2022
Q1 		$18K Sell
25,268
-353,300
-93% -$756K ﹤0.01% 2845
2021
Q4 		$855K Buy
+378,568
New +$1.03M ﹤0.01% 1265
2021
Q3 		– Sell
-62,446
Closed -$236K – 3228
2021
Q2 		$236K Sell
62,446
-201,535
-76% -$678K ﹤0.01% 2295
2021
Q1 		$893K Buy
+263,981
New +$951K 0.01% 1262
2019
Q4 		– Sell
-16,367
Closed -$64K – 1119
2019
Q3 		$64K Buy
+16,367
New +$70.1K ﹤0.01% 1287

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRT Financial's AKBA Position: Q2 2026 in Review

HRT Financial sold out of Akebia Therapeutics (AKBA) in Q2 2026, closing a stake of 976,937 shares — an estimated $1.36M sold.

HRT Financial first reported a position in AKBA in Q3 2019 and held it in 13 quarters. The position peaked at $2.61M in Q4 2025. 170 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • HRT Financial reported no remaining Akebia Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 976,937 Akebia Therapeutics shares in Q2 2026, an estimated $1.36M.
  • HRT Financial first reported a position in Akebia Therapeutics in Q3 2019 and held it in 13 quarters.
  • HRT Financial's Akebia Therapeutics position peaked at $2.61M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.